Clinical Trial

Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease

Name: Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease — clinical trial record (NCT06168994)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of atrial fibrillation in patient with structural heart disease

Trial Details

NCT Number	NCT06168994
Lead Sponsor	Assiut University
Conditions	Paroxysmal Atrial Fibrillation
Enrollment	100 participants
Start Date	2024-02-01
Primary Completion	2026-09-29 (estimated)
Study Completion	2027-05-20 (estimated)
Updated on ClinicalTrials.gov	2023-12-13